Amgen financials
$423.64+1.32%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.05B | $8.62B | $9.87B | $9.56B | $9.18B | $8.15B | $9.09B | $8.50B | $8.39B | $7.45B | $8.20B | $6.90B |
| Gross profit | $7.24B | $5.87B | $6.89B | $6.47B | $6.17B | $5.18B | $5.97B | $5.19B | $5.15B | $4.25B | $5.08B | $5.10B |
| Gross margin | 72.0% | 68.2% | 69.8% | 67.8% | 67.2% | 63.6% | 65.7% | 61.1% | 61.4% | 57.0% | 62.0% | 73.8% |
| Operating income | $3.51B | $2.67B | $2.72B | $2.53B | $2.66B | $1.18B | $2.31B | $2.05B | $1.91B | $991.0M | $1.27B | $2.02B |
| Net income | $2.38B | $1.82B | $1.33B | $3.22B | $1.43B | $1.73B | $627.0M | $2.83B | $746.0M | -$113.0M | $767.0M | $1.73B |
| Net margin | 23.6% | 21.1% | 13.5% | 33.7% | 15.6% | 21.2% | 6.9% | 33.3% | 8.9% | −1.5% | 9.4% | 25.1% |
| Diluted EPS | $4.37 | $3.34 | $2.45 | $5.93 | $2.65 | $3.20 | $1.15 | $5.22 | $1.38 | $-0.21 | $1.42 | $3.22 |
| EBITDA | $4.63B | $3.78B | $3.85B | $3.83B | $4.00B | $2.56B | $3.71B | $3.44B | $3.31B | $2.39B | $1.27B | $2.92B |
| Operating cash flow | $4.00B | $2.19B | $1.60B | $4.68B | $2.28B | $1.39B | $4.77B | $3.57B | $2.46B | $689.0M | $538.0M | $2.76B |
| Free cash flow | $3.49B | $1.48B | $961.0M | $4.25B | $1.91B | $980.0M | $4.40B | $3.31B | $2.22B | $459.0M | $289.0M | $2.51B |
| Diluted shares | 544.0M | 544.0M | 544.0M | 542.0M | 541.0M | 541.0M | 545.0M | 542.0M | 541.0M | 536.0M | 539.0M | 538.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.99B | $12.04B | $9.13B | $9.45B | $8.03B | $8.81B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $57.30B | $57.32B | $54.60B | $54.59B | $56.20B | $57.38B |
| Total assets | $95.64B | $92.50B | $90.59B | $90.14B | $87.90B | $89.37B |
| Total liabilities | $83.95B | $83.31B | $81.93B | $80.52B | $80.47B | $83.16B |
| Shareholders' equity | $11.69B | $9.19B | $8.66B | $9.62B | $7.43B | $6.21B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology